All Resources

Private Drug Coverage • September 15, 2023

Cost of A Private Drug Plan Claim

Learn more | View

Access to Medicine • August 21, 2023

IMC Response to the PMPRB’s 2023 Interim Guidance Consultation

Learn more | View

Access to Medicine • August 21, 2023

pCPA Temporary Access Process: Innovative Medicines Industry Consultation Response

Learn more | View

June 08, 2023

Submission for the parliamentary consultations on Bill 15—An Act to Make the Health and Social Services more effective

Learn more | View

Pharmacare • June 01, 2023

Addendum to Innovative Medicines Canada Submission on National Pharmacare

Learn more | View

Access to Medicine • May 16, 2023

Developing a Canadian managed entry approach for new innovation: What can Canada learn from Europe?

Learn more | View

Access to Medicine • April 04, 2023

Innovative Access Arrangements and Managed Entry

A growing number of payers in many countries are looking to managed entry agreements (MEAs) and other innovative access arrangements (IAAs) to allow rapid access to medicines that address significant…

Learn more | View

Access to Medicine • February 15, 2023

Increasing Access to Innovative Medicines

Learn more | View

Access to Medicine • February 15, 2023

Alberta Budget Submission 2023

Learn more | View

Private Drug Coverage • November 25, 2022

Cost Drivers: Analysis of Private Drug Plans in Canada 2022

Learn more | View

Access to Medicine • November 17, 2022

Innovative Agreements Framework

Learn more | View

Economic Impact • October 07, 2022

Pre-Budget Consultations in Advance of the 2023 Budget

Learn more | View